Novavax (NASDAQ: NVAX)stock was up nearly 70% year to date early last week. Then came the biotech's announcement on Wednesday that it would sell stock in a public offering to raise cash. It didn't take long for Novavax to give up a big chunk of its previous gains.
Buy Novavax After Its Latest Pullback?
Понравилась статья? Подпишитесь на канал, чтобы быть в курсе самых интересных материалов
Подписаться